CClinicalTrials.gg
CompletedNCT03586921Updated Jul 16, 2018

Primary Care Group Therapy for Depression/Anxiety for Women in Petropolis

A Phase 3 interventional study of Psychosocial Group Intervention and Enhanced Usual Care in Depression and Anxiety Disorders, sponsored by Rio de Janeiro State University. Completed. Open to female participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2018-07-16.

Sponsored by Rio de Janeiro State University · Phase 3, Interventional, and Treatment

From the registry’s dates

  • Registered 11 years 10 months after the study started (first participant enrolled May 2006, registered Mar 2018).
Phase
Phase 3
Study type
Interventional
Enrollment
340
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
Female
01

Study summary

This is a randomized controlled trial comparing two groups: 1) Enhanced usual care and 2) Enhanced usual care plus group psychological intervention. In both groups a "stepped care" approach was used to the management of anxiety and depression among women seen in primary care.

Read the detailed description

All patients received enhanced primary care, which included: (1) The nurses and doctors from the Family Health Teams were trained by Matrix team mental health professionals on clinical aspects of depression and anxiety, including diagnosis, appropriate medication interventions, psycho-education, and cognitive and problem solving therapy. (2) Given the high co-occurrence of anxiety and depression, the intervention was modified from the depression-only Chile model to emphasize co-occurring anxiety and depression in diagnoses, appropriate prescription of anxiolytics and antidepressants. (3) All providers received weekly group or individual consultation with a Matrix team mental health professional, either psychiatrist or psychologist. An qualitative study of participating Petrópolis Family Health Programme doctors and nurses demonstrated their satisfaction with the training.

Patients in the intervention arm received enhanced primary care plus a 9-session group intervention (seven sessions weekly then two sessions every 15 days). The intervention included two psycho-educational sessions with information about depression and anxiety disorders, two sessions on the development of pleasant activities including relaxation exercises, two sessions on solving problems therapy, one session on the problem of overcoming negative thoughts and emotions, one session on relapse prevention, and a final closure and review session which included a small party. The patients from the intervention arm also received additional outreach from the Family Health Teams, including home delivery of psychotropic medication when needed and active outreach and engagement by community workers if patients missed group sessions.

02

Conditions studied

  • Depression
  • Anxiety Disorders
03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's enrollment of 340 is above the median of 84 across 6,720 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Rio de Janeiro State University is the lead sponsor of 62 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • female patients who came to the primary care unit for any type of consultation for themselves (e.g., not for a child).
  • General Health Questionnaire positive screen (>5 at two time points)
  • positive diagnosis of depression or anxiety per the Mini Mental State Examination.

Exclusion criteria

Exclusion Criteria:

  • diagnosis of bipolar disorder, mania, severe suicidal ideation
  • cognitive impairment that would limit their ability to consent or take part in the study. -pregnant.
05

Study design

Phase
Phase 3
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
340 participants (actual)

Study arms

  • Experimental
    Enhanced usual care + group intervention

    Intervention patients received enhanced primary care plus a 9-session group intervention. The intervention included two psycho-educational sessions with information about depression and anxiety disorders, two sessions on the development of pleasant activities including relaxation exercises, two sessions on solving problems therapy, one session on the problem of overcoming negative thoughts and emotions, one session on relapse prevention, and a final closure and review session which included a small party. The patients from the intervention arm also received additional outreach from the Family Health Teams, including home delivery of psychotropic medication when needed and active outreach and engagement by community workers if patients missed group sessions.

    Behavioral: Psychosocial Group Intervention

  • Active comparator
    Enhanced Usual Care

    All patients received enhanced primary care: (1) Nurses and doctors from the Family Health Teams were trained by Matrix team mental health professionals on clinical aspects of depression and anxiety. (2) Given the high co-occurrence of anxiety and depression, the intervention was modified from the depression-only Chile model to emphasize co-occurring anxiety and depression in diagnoses, appropriate prescription of anxiolytics and antidepressants. (3) All providers received weekly group or individual consultation with a Matrix team mental health professional, either psychiatrist or psychologist. An qualitative study of participating Petrópolis Family Health Programme doctors and nurses demonstrated their satisfaction with the training.

    Other: Enhanced Usual Care

Interventions

  • BehavioralPsychosocial Group Intervention

    The intervention included two psycho-educational sessions with information about depression and anxiety disorders, two sessions on the development of pleasant activities including relaxation exercises, two sessions on solving problems therapy, one session on the problem of overcoming negative thoughts and emotions, one session on relapse prevention, and a final closure and review session which included a small party.

  • OtherEnhanced Usual Care

    All patients received enhanced primary care: (1) Nurses and doctors from the Family Health Teams were trained by Matrix team mental health professionals on clinical aspects of depression and anxiety. (2) Given the high co-occurrence of anxiety and depression, the intervention was modified from the depression-only Chile model to emphasize co-occurring anxiety and depression in diagnoses, appropriate prescription of anxiolytics and antidepressants. (3) All providers received weekly group or individual consultation with a Matrix team mental health professional, either psychiatrist or psychologist. An qualitative study of participating Petrópolis Family Health Programme doctors and nurses demonstrated their satisfaction with the training.

06

What researchers measure

Primary outcomes

  1. Depression (Beck Depression Inventory)

    Depression measured by the Beck Depression Inventory

    Time frame: Change in depression 4 months post intervention

  2. Depression (Beck Depression Inventory)

    Depression measured by the Beck Depression Inventory

    Time frame: Change in depression 8 months post intervention

Secondary outcomes

  1. Anxiety (Beck Anxiety Inventory)

    Anxiety as measured by the Beck Anxiety Inventory

    Time frame: 4 months post intervention

  2. Anxiety (Beck Anxiety Inventory)

    Anxiety as measured by the Beck Anxiety Inventory

    Time frame: 8 months post intervention

  3. Quality of Life (World Health Organization Quality of Life Assessment, Brief Version)

    QoL as measured by the World Health Organization Quality of Life Assessment, Brief Version

    Time frame: 4 months and 8 months post intervention

  4. Quality of Life (World Health Organization Quality of Life Assessment, Brief Version)

    QoL as measured by the World Health Organization Quality of Life Assessment, Brief Version

    Time frame: 4 months post intervention

  5. Quality of Life (World Health Organization Quality of Life Assessment, Brief Version)

    QoL as measured by the World Health Organization Quality of Life Assessment, Brief Version

    Time frame: 8 months post intervention

07

Study locations

No study locations are listed for this record.

08

References and documents

Study documents

  • Protocol and statistical analysis plan · Jul 12, 2018

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: Undecided

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 16, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03586921
Lead sponsor
Rio de Janeiro State University
Responsible party
Rosely Sichieri (Associate Professor, Rio de Janeiro State University) — Principal investigator
First posted
Jul 16, 2018
Start date
May 19, 2006
Primary completion
Sep 25, 2007
Completion
Jan 15, 2008
Last update
Jul 16, 2018

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion